Abstract

ObjectivesTo determine if predictions of the Lung Cancer Prediction convolutional neural network (LCP-CNN) artificial intelligence (AI) model are analogous to the Brock model.MethodsIn total, 10,485 lung nodules in 4660 participants from the National Lung Screening Trial (NLST) were analysed. Both manual and automated nodule measurements were inputted into the Brock model, and this was compared to LCP-CNN. The performance of an experimental AI model was tested after ablating imaging features in a manner analogous to removing predictors from the Brock model. First, the nodule was ablated leaving lung parenchyma only. Second, a sphere of the same size as the nodule was implanted in the parenchyma. Third, internal texture of both nodule and parenchyma was ablated.ResultsAutomated axial diameter (AUC 0.883) and automated equivalent spherical diameter (AUC 0.896) significantly improved the accuracy of Brock when compared to manual measurement (AUC 0.873), although not to the level of the LCP-CNN (AUC 0.936). Ablating nodule and parenchyma texture (AUC 0.915) led to a small drop in AI predictive accuracy, as did implanting a sphere of the same size as the nodule (AUC 0.889). Ablating the nodule leaving parenchyma only led to a large drop in AI performance (AUC 0.717).ConclusionsFeature ablation is a feasible technique for understanding AI model predictions. Nodule size and morphology play the largest role in AI prediction, with nodule internal texture and background parenchyma playing a limited role. This is broadly analogous to the relative importance of morphological factors over clinical factors within the Brock model.Key Points• Brock lung cancer risk prediction accuracy was significantly improved using automated axial or equivalent spherical measurements of lung nodule diameter, when compared to manual measurements.• Predictive accuracy was further improved by using the Lung Cancer Prediction convolutional neural network, an artificial intelligence-based model which obviates the requirement for nodule measurement.• Nodule size and morphology are important factors in artificial intelligence lung cancer risk prediction, with nodule texture and background parenchyma contributing a small, but measurable, role.

Highlights

  • Pulmonary nodules are a common incidental finding on computed tomography (CT) [1]

  • Predictive accuracy was further improved by using the Lung Cancer Prediction convolutional neural network, an artificial intelligence-based model which obviates the requirement for nodule measurement

  • AUC values for the Brock model were significantly higher with automatic axial diameter (0.883, 95% confidence intervals (CI) 0.870–0.895, p < 0.02) and automatic spherical diameter (0.896, 95% CI 0.883–0.907, p < 0.0001) than with manual diameter (0.873, 95% CI 0.860–0.886) (Fig. 2)

Read more

Summary

Introduction

Current guidelines emphasise the importance of assessing the likelihood that a nodule is malignant, with further management being dependent on the predicted risk of malignancy [2, 3]. The Brock University model is a LR model that has been successfully validated in a screening cohort from the National Lung Screening Trial (NLST) in the USA and in an unselected clinical population in the UK [4–8]. The British Thoracic Society (BTS) guidelines recommend the use of the Brock model in clinical practice, whilst the Fleischner Society guidelines do not advocate any risk prediction model but do acknowledge that the Brock model is of great interest [2, 3]. Nodule size, defined as the maximum diameter of the long axis of the nodule measured by a thoracic radiologist using electronic callipers, is the single most important predictor in the Brock model [8]. Other predictors of cancer in this model include older age, female sex, family history of lung cancer, emphysema, upper lobe nodule location, part-solid nodule, lower nodule count, and spiculation

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call